Step 1 topics → Immunology → Type IV Hypersensitivity (T Cell / Delayed)

Type IV Hypersensitivity (T Cell / Delayed)

USMLE Step 1 trap: Incorrectly attributes antibody involvement to Type IV hypersensitivity. Type IV is the only hypersensitivity type that is entirely antibody-independent, mediated solely by sensitized T cells (CD4+ Th1 and CD8+ CTLs).

Type IV hypersensitivity is the one hypersensitivity type that breaks the pattern — no antibodies, no complement, just T cells doing damage. That distinction is exactly what USMLE Step 1 exploits. The classic teaching is 'delayed type hypersensitivity,' and the 48–72 hour timeline is the signature: think PPD skin test induration, poison ivy rash, or nickel contact dermatitis appearing days after exposure, not minutes. The mechanism is sensitized CD4+ Th1 cells (and CD8+ CTLs in some contexts) recognizing antigen presented by APCs, releasing cytokines like IFN-γ to recruit and activate macrophages. When macrophages can't clear the antigen, they fuse into giant cells and form granulomas — which is why TB, sarcoidosis, and Crohn's all live in this category.

The exam tests this from multiple directions: pure mechanism recall, disease classification (which conditions belong here vs. Type II or III), and clinical interpretation of the PPD. The PPD angle is particularly high-yield because it requires you to apply the mechanism to a diagnostic scenario — a positive result means prior sensitization, not active disease, and a negative result doesn't rule out TB if the patient is anergic. That last point is where students consistently lose points.

What makes Type IV tricky is scope creep — most students know contact dermatitis and PPD, but the concept extends to acute cellular transplant rejection, multiple sclerosis, type 1 diabetes, and Hashimoto thyroiditis. USMLE Step 1 loves hiding these in vignettes where you have to recognize the T cell–mediated mechanism without being handed the label. The other trap is the timing: students who know the 48–72 hour delay sometimes attribute it to slow antibody production, which is the wrong model entirely.

From real student decks
85%have cards covering this topic
75%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Type IV hypersensitivity involves antibodies because other hypersensitivity types do.
Right: Type IV is the only hypersensitivity type that is entirely antibody-independent, mediated solely by sensitized T cells (CD4+ Th1 and CD8+ CTLs).
Type IV is the only hypersensitivity type that is completely antibody-independent — this is its defining feature. Types I, II, and III all require antibodies (IgE, IgG/IgM, and immune complexes, respectively), so it's easy to assume Type IV follows the same pattern. It doesn't: the effector cells are sensitized T cells, and blocking B cells or antibodies has no effect on this reaction.
Common mistake
Wrong: A negative PPD always means the patient has never been exposed to TB.
Right: A negative PPD can be a false negative due to anergy from immunocompromise (e.g., HIV, sarcoidosis, malnutrition, steroids) or miliary TB overwhelming the immune response.
A negative PPD only means the immune system didn't mount a detectable T cell response at the skin site — it does not confirm absence of TB exposure. In immunocompromised patients (HIV with low CD4 count, chronic steroid use, malnutrition, sarcoidosis) or in overwhelming miliary TB, the T cell response is globally suppressed, producing anergy and a false negative. Always interpret PPD results in the clinical context of the patient's immune status.
Common mistake
Wrong: Type IV hypersensitivity only includes contact dermatitis and PPD reactions.
Right: Type IV also includes transplant rejection (acute cellular), multiple sclerosis, type 1 diabetes, Hashimoto thyroiditis, and granulomatous diseases such as TB and sarcoidosis.
Contact dermatitis and PPD are the classic teaching examples, but they represent only a slice of Type IV. Anywhere the immune response is driven by T cells damaging tissue directly — granuloma formation in TB and sarcoidosis, T cell attack on myelin in MS, beta cells in type 1 diabetes, thyroid in Hashimoto, or donor tissue in acute cellular rejection — you are looking at Type IV. The unifying theme is T cell–mediated injury, not the specific tissue or clinical syndrome.
Common mistake
Wrong: The 48–72 hour delay in Type IV reactions is due to slow antibody production.
Right: The delay reflects the time required for antigen-presenting cells to recruit and re-activate memory T cells at the site, with no antibody involved.
The 48–72 hour delay has nothing to do with antibody production kinetics. Antibodies aren't involved at all. The delay reflects the biology of T cell recruitment: after antigen is processed and presented, memory T cells must be found, re-activated, and traffic to the site, then begin secreting cytokines like IFN-γ to recruit macrophages. This multi-step cellular process simply takes days, not hours.
Guided session

Stuck on this? An AI tutor that probes your understanding and catches where your reasoning breaks.

Start a session →
Free Deck audit

Already run Anki? See if your deck covers this topic.

Upload your deck →

What the exam tests

  1. Understand the mechanism of Type IV hypersensitivity — specifically that it is mediated entirely by sensitized T cells (CD4+ Th1 and CD8+ CTLs) with no antibody or complement involvement, and explain why the response is delayed by 48–72 hours.
  2. Classify diseases correctly as Type IV hypersensitivity, including contact dermatitis, PPD reactions, granulomatous diseases (TB, sarcoidosis, Crohn's), acute cellular transplant rejection, and T cell–driven autoimmune diseases (MS, type 1 diabetes, Hashimoto thyroiditis).
  3. Interpret a PPD (tuberculin) test result correctly — knowing that induration represents a positive result due to prior sensitization, and that a negative PPD can be a false negative in anergic patients (HIV, malnutrition, sarcoidosis, steroid use, miliary TB).

Can you avoid these mistakes?

A patient with a history of TB exposure receives a PPD test and shows 0 mm of induration at 72 hours. His CD4 count is 85 cells/μL. How do you interpret this result, and what is the mechanism behind it?
A vignette describes a patient on chronic immunosuppression who receives a kidney transplant. One week later, a biopsy shows lymphocytic infiltration of the graft with tubulitis. What type of hypersensitivity is this, and which specific cells are responsible?
You see four patients: one with urticaria minutes after eating peanuts, one with Goodpasture syndrome, one with serum sickness after a horse antitoxin, and one with a positive PPD reaction at 72 hours. Which patient's reaction does NOT involve antibodies? Identify the effector cells responsible for that patient's reaction and explain why the 48–72 hour timeline rules out an antibody-mediated mechanism.
A patient develops a pruritic, weeping rash in the shape of a watch band 48 hours after wearing a new metal watch. Describe the sequence of immunologic events from first exposure (sensitization) to the current presentation (elicitation), naming the cell types and key cytokines involved.

Related topics

T Helper Subsets and Treg Thymus and T Cell Maturation Spleen Architecture and Function Lymph Node and MALT Architecture Innate Immune Cells Overview

Find out what you actually understand about this topic — a tutor that probes your reasoning and catches where it breaks.

Start a session →

Already run Anki? Get a free deck audit →